微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
格隆汇3月14日丨Myomo(MYO.US)盘前继续上涨8.44%,报0.835美元,该股月内累计涨幅近20%,且昨日涨4%创阶段新高。公司2022年Q4财报实现营收404.2万美元,前值为403.2万美元,预期值为406万美元;每... 网页链接
$Myomo(MYO)$ 8-K - Current report Filed: 2019-06-06 AccNo: 0001193125-19-167193 Size: 21 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Myomo(MYO)$ 8-K - Current report Filed: 2019-05-22 AccNo: 0001193125-19-154043 Size: 41 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial Statemen...
$Myomo(MYO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-14 AccNo: 0001564590-19-019136 Size: 4 MB 网页链接
$Myomo(MYO)$ 8-K - Current report Filed: 2019-05-13 AccNo: 0001193125-19-144762 Size: 125 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Myomo(MYO)$ 美东时间 2019-05-13 盘前 披露财报,预期EPS -0.2 网页链接
$Myomo(MYO)$ DEF 14A - Other definitive proxy statements Filed: 2019-04-26 AccNo: 0001193125-19-122301 Size: 639 KB 网页链接
$Myomo(MYO)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-04-26 AccNo: 0001193125-19-122328 Size: 223 KB 网页链接
$Myomo(MYO)$ 8-K - Current report Filed: 2019-04-03 AccNo: 0001193125-19-096626 Size: 15 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Myomo(MYO)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-03-14 AccNo: 0001193125-19-074805 Size: 43 KB 网页链接
$Myomo(MYO)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-03-12 AccNo: 0001564590-19-007350 Size: 9 MB 网页链接